Key statistics
On Friday, Anteris Technologies Global Corp (AVR:ASX) closed at 7.40, 73.71% above the 52 week low of 4.26 set on Apr 15, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 7.42 |
|---|---|
| High | 7.59 |
| Low | 7.30 |
| Bid | 7.31 |
| Offer | 7.59 |
| Previous close | 7.80 |
| Average volume | 34.97k |
|---|---|
| Shares outstanding | 91.71m |
| Free float | 89.93m |
| P/E (TTM) | -- |
| Market cap | 730.10m AUD |
| EPS (TTM) | -- |
Data delayed at least 20 minutes, as of Feb 06 2026 04:52 GMT.
More ▼
- Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises
- Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
- Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
- Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic
- Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
- Anteris Announces Results for the Third Quarter of 2025
- FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
- Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
- Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
- Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
More ▼
